Tocofersolan
(Synonyms: 维生素E聚乙二醇琥珀酸酯,TPGS; D-α-Tocopherol polyethylene glycol 1000 succinate; Vitamin E-TPGS) 目录号 : GC31315A nonionic surfactant
Cas No.:9002-96-4
Sample solution is provided at 25 µL, 10mM.
Tocofersolan is a nonionic surfactant and derivative of vitamin E.1 It has a critical micelle concentration (CMC) of 0.02 mM at room temperature. Tocofersolan inhibits P-glycoprotein (P-gp), also known as multidrug resistance protein 1 (MDR1), substrate-induced ATPase activity in cell-free assays (IC50s = 0.4-3.25 ?M).2 It reverses locomotor deficits induced by the polycyclic aromatic hydrocarbon benzo[a]pyrene in zebrafish larvae when used at a concentration of 1 ?M.3 Intravenous administration of nanocrystals containing tocofersolan (50 mg/kg) and paclitaxel reduces tumor growth in an NCI/ADR-RES mouse xenograft model.4
1.Sadoqi, M., Lau-Cam, C.A., and Wu, S.H.Investigation of the micellar properties of the tocopheryl polyethylene glycol succinate surfactants TPGS 400 and TPGS 1000 by steady state fluorometryJ. Colloid Interface Sci.333(2)585-589(2009) 2.Collnot, E.-M., Baldes, C., Wempe, M.F., et al.Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: Influence on ATPase activity and membrane fluidityMol. Pharm.4(3)465-474(2007) 3.Holloway, Z., Hawkey, A., Asrat, H., et al.The use of tocofersolan as a rescue agent in larval zebrafish exposed to benzo[α]pyrene in early developmentNeurotoxicology8678-84(2021) 4.Liu, Y., Huang, L., and Liu, F.Paclitaxel nanocrystals for overcoming multidrug resistance in cancerMol. Pharm.7(3)863-869(2010)
Cas No. | 9002-96-4 | SDF | |
别名 | 维生素E聚乙二醇琥珀酸酯,TPGS; D-α-Tocopherol polyethylene glycol 1000 succinate; Vitamin E-TPGS | ||
Canonical SMILES | CC1=C(CCC(CCCC(C)CCCC(C)CCCC(C)C)(C)O2)C2=C(C)C(C)=C1OC(CCC(OCCO)=O)=O.[n] | ||
分子式 | C35H58O6 | 分子量 | 1513.00 |
溶解度 | DMSO : 31.25 mg/mL (20.65 mM);Water : < 0.1 mg/mL (insoluble) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 0.6609 mL | 3.3047 mL | 6.6094 mL |
5 mM | 0.1322 mL | 0.6609 mL | 1.3219 mL |
10 mM | 0.0661 mL | 0.3305 mL | 0.6609 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet